RLMD: Relmada Therapeutics Earnings growth forecast for next year
Relmada Therapeutics develops innovative antidepressants, offering rapid onset of action with low addiction risks. The projected change in earnings per share for the coming year allows for an assessment of market expectations, where the value -33.00 describes the current level. Relmada Therapeutics aims for expansion in neuropharmaceuticals by scaling REL-1017, completing final Phase III trials to launch sales in the US.
relmada.com - analytical breakdowns and key metrics (RLMD)
- share price and consensus valuation forecast:
- market capitalization information:
- book capitalization indicators:
- debt and liquidity details:
Total Debt to Capital Relmada Therapeutics|RLMD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Relmada Therapeutics, Inc.|RLMD - Company Cumulative Debt|Debt to Book Capitalization Ratio Relmada Therapeutics|RLMD - Company Long-Term Loans and Borrowings|Company Short-Term Debts Relmada Therapeutics|Quick Liquidity relmada.com
- earnings and market ratios statistics:
RLMD - Profit After Tax|Projected Future Earnings Relmada Therapeutics|RLMD - Market Cap to Earnings|Projected Price to Earnings Relmada Therapeutics|RLMD - PEG Multiple|Enterprise Value to EBITDA Ratio Relmada Therapeutics|RLMD - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Relmada Therapeutics|RLMD - Net earnings per share for the last four quarters|Quarterly EPS earnings growth relmada.com|RLMD - Net earnings per share growth this year|Net earnings per share growth forecast for next year Relmada Therapeutics
- sales and revenue indicators:
Fundamental company analysis:RLMD, Relmada
The investment potential assessment for Relmada Therapeutics (RLMD) is based on comparing the current share price with the expected earnings per share. The trend in consensus EPS forecasts for the coming year reflects the average expert growth rate for net income, allowing market noise to be filtered out from real trends. For Relmada Therapeutics (RLMD), this indicator confirms the monetization of antidepressants, where high patient loyalty guarantees a stable cash flow.
Competitor analysis for Relmada Therapeutics
BIIB (Biogen Corp) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year NBIX (Neurocrine Corp)|Earnings growth forecast for next year RGC|Earnings growth forecast for next year axsome.com (AXSM)|ACADIA Pharmaceuticals Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year XENE|VKTX: Expected earnings per share growth for next year|Supernus Corp - Projected earnings per share increase next year|CPRX: Earnings growth forecast for next year|denalitherapeutics.com - Expected earnings per share trend next year|HRMY (Harmony Biosciences Holdings, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year Biohaven Ltd BHVN|Net earnings per share growth forecast for next year Amylyx (AMLX)|TRVI (Trevi Corp) - Expected earnings per share trend next year|Earnings growth forecast for next year PRAX (Praxis Precision Medicines)|Earnings growth forecast for next year anavex.com AVXL|CBLL - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PRTA|ALEC: Earnings growth forecast for next year|Expected net earnings per share growth next year Annexon Biosciences Inc. (ANNX)|Expected earnings per share growth for next year OMER|Earnings growth forecast for next year neurogene.com|Expected earnings per share growth for next year ACIU (AC Immune SA)|Projected earnings per share increase next year VYGR|Earnings growth forecast for next year NMRA (Neumora Therapeutics Inc)|Consensus forecast of earnings per share growth for next year Scilex Holding Company, Inc. (SCLX)|Tevogen Bio Holdings - Earnings growth forecast for next year|Alpha Cognition (ACOG) - Expected earnings per share growth for next year|Cognition Therapeutics (CGTX) - Net earnings per share growth forecast for next year|IKT - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Cassava|ASRT: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Coya Therapeutics, Inc. (COYA)|Net earnings per share growth forecast for next year VTGN (vistagen.com)|Net earnings per share growth forecast for next year Ovid Therapeutics OVID|ABOS - Expected earnings per share growth for next year|CervoMed Inc - Earnings growth forecast for next year|ATHE (Alterity Therapeutics) - Projected earnings per share growth rate for next year|clene.com (CLNN) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year PEPG|JUNS (Jupiter Neurosciences Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year Annovis Bio Inc ANVS|Expected earnings per share growth for next year GRCE (Grace Therapeutics, Inc.)|Earnings growth forecast for next year Firefly Neuro (AIFF)|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|Expected earnings per share trend next year NRSN|RVPH - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year MetaVia Inc|NeurAxis, Inc (NRXS) - Net earnings per share growth forecast for next year|Helius Medical Technologies - Expected earnings per share trend next year|PASG (Passage Bio Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year Neuphoria NEUP|Net earnings per share growth forecast for next year Minerva Neurosciences, Inc. (NERV)|Net earnings per share growth forecast for next year ATHA (Athira Pharma Inc)|Net earnings per share growth forecast for next year Addex Therapeutics, Ltd. ADXN|ALZN - Expected earnings per share growth for next year|Cyclerion - Earnings growth forecast for next year|PTIX - Earnings growth forecast for next year|KTTA: Earnings growth forecast for next year|Projected earnings per share growth rate for next year CRGT|ATXI (Avenue Therapeutics, Inc) - Earnings growth forecast for next year|Earnings growth forecast for next year BrainStorm Cell Therapeutics Inc.|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|CHRO (chromocell.com) - Expected earnings per share trend next year|Eliem Therapeutics Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year ITCI (Intra-Cellular Therapies Inc.)|Longboard Pharma - Earnings growth forecast for next year|Expected earnings per share trend next year MRNS (Marinus Pharma)|NKGN: Earnings growth forecast for next year|Expected net earnings per share growth next year neurobopharma.com (NRBO)|Net earnings per share growth forecast for next year Sage Therapeutics|SNPX: Expected earnings per share trend next year|Earnings growth forecast for next year TRVN|Earnings growth forecast for next year vigilneuro.com (VIGL)|Net earnings per share growth forecast for next year Anew Medical WENA|CERE (cerevel.com) - Net earnings per share change forecast for next year
